2012 Movember Clinician Scientist Awards











Prostate Cancer Canada would like to recognize the Movember Foundation as a key funder of this program.

Prostate Cancer Canada is pleased to announce the awarding of two Movember Clinician Scientist Awards.

In order to decide which research projects should receive funding, each application is thoroughly reviewed by at least two cancer experts. These experts make recommendations to PCC regarding which research projects to fund. This process is called 'peer review'. The peer review process ensures that only the most meritorious research is supported. This year's successful research projects explore many different areas of prostate cancer including novel treatment therapies and the development of new tools to help better predict disease progression.


Movember Clinician Scientist Awards

Investigator Host Institution Project Title Total Award  Award Period        
Peter Black University of British Columbia Circulating tumour cells in prostate cancer: the metastatic window $300,000  July 1, 2012- June 30, 2014
Girish Kulkarni Princess Margaret Hospital        Biopsy avoidance in patients at risk for prostate cancer and in patients with low risk prostate cancer: developing tools for personalized medicine $300,000 July 1, 2012 -
June 30, 2014

 


Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More

Prostate Cancer Canada launches first national program in radioligand therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More


Click here for news archive